ABCELLERA TO ANNOUNCE TOP-LINE RESULTS FROM THE PHASE 2 TRIAL OF ABCL635 FOR THE TREATMENT OF MODERATE-TO-SEVERE VMS DUE TO MENOPAUSE ON MONDAY, AUGUST 10, 2026

Reuters · 1d ago

Please log in to view news